Imunon, Inc. is a biotechnology company focused on developing innovative therapeutic solutions for cancer and infectious diseases. The company utilizes a proprietary platform to create novel immunotherapies that enhance the body’s immune response against tumors and pathogens. Imunon is dedicated to advancing its research and product development pipeline, aiming to address critical unmet medical needs and improve patient outcomes through its specialized approach to immunotherapy and drug development. Read More
Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.9 million. Imunon (NASDAQ:IMNN) shares moved upwards
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now available for on-demand viewing.
